About
Condensate Targeting, Undruggable Proteins
Areas of Focus
Categories
Small Molecule PharmaceuticalChina
Clinical Trials (6)
View allTotal Trials
6
As Lead Sponsor
6
As Collaborator
0
Total Enrollment
446
By Phase
PHASE1/PHASE2: 3PHASE1: 3
By Status
RECRUITING: 5NOT_YET_RECRUITING: 1
Clinical Trials Pipeline6 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2022
2023
2024
2025
2026
2027
2028
2029
Today
Hover over trial bars to see details
Recent Trials
NCT07010835Lead Sponsor
Study of YK012 in Moderate to Severe Systemic Lupus Erythematosus
PHASE1/PHASE2Not yet recruiting
189 participants
Started: Aug 31, 2025 · Completed: Dec 31, 2028
NCT06982729Lead Sponsor
Study of YK012 in Primary Membranous Nephropathy
PHASE1Recruiting
72 participants
Started: Mar 8, 2025 · Completed: Dec 31, 2027
NCT06580301Lead Sponsor
Study of YK012 in B-cell Acute Lymphoblastic Leukemia
PHASE1/PHASE2Recruiting
46 participants
Started: Sep 25, 2024 · Completed: Jun 30, 2027
NCT06574568Lead Sponsor
A Study of YKST02 in Participants with Relapsed or Refractory Multiple Myeloma
PHASE1Recruiting
70 participants
Started: Jun 14, 2024 · Completed: Jun 30, 2027
NCT06343311Lead Sponsor
T-Cell Therapy (EB103) in Adults With Relapsed/Refractory B-Cell Non-Hodgkin's Lymphoma (NHL)
PHASE1/PHASE2Recruiting
21 participants
Started: Jun 1, 2024 · Completed: Dec 31, 2027
Locations (1)
Headquarters
Shanghai, China
Map
Loading map...